Skip to content

Virtual Reality - Cognitive Behavioral Therapy for Depression (VR-CBT-D)

Virtual Reality - Cognitive Behavioral Therapy for Depression (VR-CBT-D): The effect on depressive symptoms, automatic negative thoughts and social avoidance

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON24473
Enrollment
18
Registered
2020-10-05
Start date
2020-07-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depressive disorder

Interventions

After a randomized baseline waiting list period, ranging from 4-6 weeks, each participant follows the same intervention according to the VR-CBT treatment protocol for depression (VR-CBT-D). The treatm

Sponsors

GGZ Delfland
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - major depressive disorder according to the Diagnostic and Statistical Manual, 5th edition - age between 18 and 65 years - in possession of a smartphone with internet access - proficiency in the Dutch language (spoken and written). Participants must be able to follow therapy in Dutch and read Dutch questionnaires

Exclusion criteria

Exclusion criteria: - an acute risk of suicide, estimated by the practitioner by means of a suicide assessment - a co-morbid psychotic disorder - co-morbid alcohol and/or drug dependence - mental retardation - participation in other psychological treatments during the research

Design outcomes

Primary

MeasureTime frame
Severity of depressive symptoms (item-total correlation of QIDS-SR)

Secondary

MeasureTime frame
Severity of automatic negative thoughts (5 items of ATQ-30) and the extent of social avoidance behavior (subscale Social Impairment BADS). It is also examined whether these independent variables have a mediating role in the severity of depressive symptoms. Exploratory research is conducted into the extent to which the VR environment is perceived as realistic (IPQ) and patients are satisfied with VR (SRS).

Contacts

Public ContactLisette Louer - van Eck

GGZ Delfland

l.vaneck@ggz-delfland.nl015-2608776

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)